Page 3 - Microcap Daily News Today

Music Licensing, Inc. (OTC: SONG) shares skyrocket a whopping 100% gain at the time of writing, marking an incredible 1250% surge since their October low of $0.0004. Many appear to be wondering the cause behind the sudden rise and after today’s spike we decided to do more research. Let’s dig into the company and its […]

TG Therapeutics (NASDAQ:TGTX) concluded its most recent trading session with a closing price of $10.25, showcasing a remarkable 56.9% increase since the stock’s October low of $6.53. This stock was on quite a roll last week, surging by a staggering 65.6%. What’s fuelling this impressive growth? The company has seen triple-digit sales and earnings per […]

Over the past month, BlueFire Equipment Corporation (OTC: BLFR) has witnessed an astounding surge of 1900%, soaring from its recent low of approximately $0.021 to a peak of $0.42. While it has recently stabilized at around the $0.34 mark, several noteworthy announcements have emerged, capturing the attention of online investors. Nevertheless, it remains somewhat undiscovered […]

A2Z Smart Technologies (NASDAQ: AZ), a prominent player in the realm of cutting-edge technology solutions, has garnered the attention of investors with surges peaking ~130% earlier this year. Intrigued by their recent developments, we decided to delve into the company’s core offerings. They’ve had a number of noteworthy announcements scaling their smart technology globally, with […]

3DX Industries (OTCPNK: DDDX) recently experienced a significant upswing, with a notable 58% surge in its stock price last week following the company’s announcement of JCP compliance. While this marks a significant milestone for the company, the broader question revolves around whether its future prospects justify the potential for further gains beyond the recent surge. […]

FingerMotion, Inc. (NASDAQ: FNGR) is steadily gaining attention from online investors as the company takes a stand against potential fraudulent short activity. We've previously covered FNGR, most notably in articles from July and September. However, the latest developments are too significant to ignore, prompting us to revisit the subject. Just recently, FNGR issued a press

Galera Therapeutics (NASDAQ: GRTX) experienced a significant 34% intraday surge on October 18, 2023. This explosive trading has captured the attention of investors, prompting curiosity about the company's efforts to innovate radiotherapy in cancer treatment. Despite the lack of updates on social media, press releases, or SEC filings, this sudden rise has left many intrigued

SAB Biotherapeutics (NASDAQ: SABS), gained 28% today as the clinical-stage biopharmaceutical company pioneering a novel immunotherapy platform received approval from the Australian Human Research Ethics Committee (HREC) to initiate the first-in-human Phase 1 clinical trial of SAB-142. Type 1 Diabetes Asset: SAB-142 is a fully-human anti-thymocyte immunoglobulin designed to modify the progression of type 1

Astra Energy Inc. (OTCQB: ASRE) has witnessed a significant shift in its market valuation since this summer of 2023, boasting an impressive growth of approximately 280% from the lows in July to the peaks in September. Additionally, the company has gained substantial traction among online investors, attributed to its ongoing initiatives to advance renewable and

Nkarta, Inc. (Nasdaq: NKTX) is making headlines with a staggering 120% surge in its share value at the present time of writing. This remarkable growth is attributed to the biopharmaceutical company's groundbreaking work in engineered natural killer (NK) cell therapies and its recent approval from the U.S. Food and Drug Administration (FDA). For a clearer